IE Business Daily Business news for the Inland Empire.
One of the largest makers of generic drugs in the United States will convert its Corona facility into a manufacturing site for oral contraceptives.
Actavis, which used to be Watson Pharmaceuticals before it changed its name and moved its corporate headquarters from Corona to New Jersey, announced the change last week, according to a report originally published in The Press-Enterprise.
Fifty-six workers were laid off as a result of the change, and it was not known how many people will remain on the job, according to the report.
Actavis was founded as Watson Pharmaceuticals in 1984. The company makes a variety of products that treat a variety of ailments, including high cholesterol, coughing, attention deficit disorder and urinary tract problems, according to the report.
